Induced Pluripotent Stem Cell
|
|
- Berenice Reed
- 5 years ago
- Views:
Transcription
1 Induced Pluripotent Stem Cell When eventually mastered, the processes involved in the obtaining, cultivating and differencing ESC into cells of clinical interest, another practical limitation should be taken into account. In spite of the fact that HSC Banks may eventually be created allowing the establishment of large collections, the ESC would have their use restricted to hystocompatible receptor. One of the alternatives to the creation of a ESC bank involves the reprogramming of the nucleus of somatic cells in the case of a patient with no donor, by the cytoplasm of an oocyte to obtain autologous hesc. This approach is also known as therapeutic cloning, since it does not want to generate a cloned individual, but only ESC for therapeutic use. The reprogramming of the somatic nucleus induced by oocyte cytoplasm resulted from the presence of different molecules, including transcription factors and other proteins. Recently, several groups reported the induction of pluripotency in human primary fibroblasts through their transduction with viral vectors expressing the OCT4, C-MYC, KLF4 and SOX2 genes. The so called induced pluripotential stem cells (ips) have the characteristic morphology of ESCs. Express pluripotential cell markers and are capable of differentiation in vitro and in tissues derived from the three embryonic layers. This way, the generation of ips from somatic cell induction by specific factors could represent an alternative to obtain of histocompatible stem cells. Preliminary results of Dr. Dimas Tadeu Covas group from Hemocentro de Ribeirão Preto (USP) show the efficiency in the lentiviral production, in the stem cell transduction (mesenchymal and endothelial progenitor) and also in the endothelial progenitor expression profile with Nanog. Thus, this group, with the subproject 5, named Gene Modification of stem cell, has as general objective the genetic change of mesenchymal stem cell and endothelial progenitor cells with lentiviral vectors carrying the stemness genes, to transform multipotent cells into pluripotent ones with greater in vitro expansion capacity. The project has the following approaches: a) To transduce MSC with 1054-CIGWS lentiviral vector carrying one of the transcription factors (Nanog, Oct3/4, Sox 2, β-catenina, Kfl4, c- myc, Esrrb, Tcl 1and Tbx 3) together with the GFP gene sort out the positive cells by flow cytometry; b) transductions will be made one at a time and afterwards four vectors at the same time will be used to induce de ips; c) Evaluation of the
2 changes in the gene expression profile of the transduced cells; d) Evaluation of the morphological changes of the transformed cells; e) assess the specific embryonic stem cells markers (alkaline phosphatase and/or SSEA-1 antigens) e) evaluate if the modified cells have acquired pluripotenciality. A great limitation of pre-clinical studies with ESCs is the lack of large animal models on which these test can be performed since a series of technical/ biological difficulties prevent the establishment of ESCs from embryos of those models. Keeping this in mind, the group coordinated by Dr. Lygia da Veiga Pereira of USP in São Paulo (USP-SP) through subproject 6, entitled Establishment of induced pluripotent stem cell lines (ips) in large animal models, intends to develop a methodology to establish lines of ips from large animal models specifically from non-human primates and canine. The cells generated will be used in pre-clinical studies of lesion of spinal cord in the respective animal models. For that matter, lentiviral vectors of AddGene enterprise (EUA) will be transferred to 293 cells by co-transfection with packing vectors. Cultures of dogs and monkeys will be transduced with lentivirus expressing the reporter gene GFP for evaluation of transduction efficiency with different packing systems; fibroblast transduction animals with induction vectors according to conditions established above, and isolation of ips in culture medium specific for ESC (in case we are not able to establish the ips by using vectors with human genes of induction, the homologous of each species will be isolated by RT-PCR from embryos, pre-implantation and new species-specific vectors will be constructed and used for induction); characterization of pluripotentiality of ips by immunofluorescence, in vitro differentiation in embryonic bodies and in vivo by the measurement of the formation of teratomas; neural differentiation of animal ips by culture in media with retinoic acid; transplant of differentiated cells in spine cord lesion models. Despite the fact that is inadequate for clinical use, the ips are an important tool of basic research, mainly for cells obtained from individuals with genetic diseases Thus, the group headed by Dr. Lygia da Veiga Pereira, through subproject 7, entitled Establishment of induced pluripotent stem cell lines (ips) from fibroblasts of patients with Mendelian and multifactorial genetic diseases (with genetic component), intends to implement the methodology of generation of human ips so that it is possible to establish ips from different tissues of patients with genetic diseases of interest to the group, particularly patients who have
3 osseous dysplasia, type 1 diabetes, multiple sclerosis and acute promyielocytic leukemia. The ips established will be used as experimental model for the study of basic mechanisms behind the respective diseases. Furthermore, new vectors based on adenovirus will be constructed, which will not integrate to the genome, so nonmodified ips will be generated, which is better suited for clinical use. For that purpose, the following experimental approaches will be used: lentiviral vectors of AddGene enterprise (EUA) will be inserted into 293 cells by transient cotransfection with vectors; frozen mesenchymal cells of the bone marrow of patients who have type 1 diabetes and leukemia PMA cells will be expanded in culture for viral transduction; standardization of line establishment of adequate cells for induction from human peripheral blood; transduction of human cells with lentiviral vectors and selection of ips cells in culture medium for ESCs; postimmunofluorescence characterization of ips and FACS using pluripotent cell markers (OCT4, NANOG, SSEA-1,2,3,4); differentiation into embryoid bodies and characterization by immunofluorescence; teratoma formation in SCID mice; characterization of pluripotency of ips through immunofluorescence, perform differentiation into embryoid bodies in vitro, and teratoma formation assays in vivo. Although techniques for the induction of pluripotency involving the incorporation of transcription factors in the genome of somatic cells (Takahashi et al., 2006) constitute a possible approach to autologous cell therapy, it is important to stress that the practical application of cells induced to differentiation by genetic modification still has to be studied further and evaluated (Liu, 2008). On the other hand, the technique of nuclear transfer (NT) is well-established and has been capable of producing healthy animals, confirming the efficient capacity of reprogramming of a differentiated cell (Wilmut et al., 1997; Keefer et al., 2000). Additionally, when used as a receptor, the cytoplastic bovine cell has been capable of reprogramming differentiated cells from various species (Chen et al., 2002, Ilmensee et al., 2006), supporting the initial view that embryonary development is necessary for the isolation of embryonary stem cells. Together with the efficient reprogramming of the cytoplasm, the abundance and the ease in obtaining biological material makes the bovine the perfect model for the establishment of efficient methods for obtaining pluripotent cells of embryonic origin through the
4 reprogramming of differentiated somatic cells of various species (Cibelli et al, 1998). By keeping that in sight, the group coordinated by Dr. Flavio Vieira Meirelles (from now on called group) of USP in Pirassununga (USP) through subproject 8, entitled Autologous pluripotent cells generated from differentiated somatic cells, will have as a general goal to characterize methodologies to obtain pluri/totipotent cells from somatic cells, in term of morphology, genetic expression and epigenetic studies. For that matter, a bovine somatic cell line derived from the in vitro cultivation of adult fibroblasts will be initially established. Part of these cells will be used in the lentiviral transduction of transcription factors responsible for cellular dedifferentiation (Takahashi et al., 2006). Such cells will be characterized in the bovine model and, along with the non-modified cells; they will be used as nuclei donors in the process of nuclear transfer. Embryonary cells derived from those processes will be compared among themselves and with those somatic undifferentiated cells in terms of morphology as well as genetic expression and epigenetic expression. They will also be compared to the embryonary cells obtained by the natural fertilization processes. The one methodology that provides characteristics closes to the ones of the control group will be considered the most appropriate for the production of stem cells from differentiated somatic cells and, so, it will be utilized in the interspecific model where pluripotency cells of primates will be produced. The reprogramming of the nucleus of somatic cells by the cytoplasm of an oocyte implies in the combination between the nuclear genome of an individual and the mitochondrial of another. Considering the great potential of this kind of approach in the development of the future of cell therapy, the control of the inherited mitochondrial is very important to make possible i) the production of human stem cells by the reprogramming of the nucleus donor cell in non-human cytoplasm and, ii) the production of autologous human stem cells (Illmensse et al., 2006). For that matter, the bovine model is interesting because of the abundance of material available and for the great quantity of available knowledge on the mechanisms that regulate the mitochondrial DNA (mtdna) during embryogenesis. In bovine embryos produced by nucleus transfer of somatic cells, the percentage of mtdna of the nucleus donor cell rises between the third and fourth cellular cycle in relation to the mtdna that comes from the oocyte (Ferreira et al., 2007). On the other hand,
5 the centrifugation of bovine zygotes makes the mechanical depletion of part of the mitochondria possible without compromising the embryonic development because the embryo is capable of replacing the same content of mtdna observed in undepleted blastocysts (Chiaratti et al., 2008). Furthermore, through mitochondrial depletion it is possible to introduce a greater quantity of exogenous mitochondrial zygotes (Ferreira et al., submitted). After what has been exposed, the group coordinated by Dr. Flavio Vieira Meirelles (from now on called group) of USP in Pirassununga (USP) through subproject 9, entitled Animal models to study mitochondrial inheritance intra- and interspecies, will have as a general goal, to evaluate the viability of production of embryos having mtdna of inner and interspecific somatic origin and to increase the percentage of such mtdna inherited by the blastocysts. More specifically, they intent to produce bovine blastocysts (Bos taurus) that present mtdna from inner or interspecific somatic origin (B. indicus or Homo sapiens, respectively), in heteroplasmia with mtdna from embryonic origin (inherited from the oocyte) and; additionally develop a method to raise the inherited percentage in blastocysts of somatic mtdna (B. indicus or H. sapiens). For that, the following technological approaches will be used the establishment of mesenchymal cell lines originated from the B. indicus and H. sapiens; enucleation of mesenchymal cells by centrifugation and cytoplasm fusion for utilization as a cytoplasm donor (Marchington et al., 1999; Shay et al., 1975); in vitro production of bovine zygotes (B. taurus) parthenogenetic oocytes aspirated from ovaries collected on the slaughterhouse and matured in vitro (Méo et al., 2007); centrifugation of zygote to concentrate the mitochondria in one of the poles of the embryo and the removal of part of the mitochondrias through micromanipulation (Ferreira et al., submitted); cytoplasts fusion (B. indicus or H. sapiens) to deplete zygote (B. taurus) and in vitro cultivation (Inoue et al., 2000); determination of the percentage of mtdna (somatic mtdna in relation to the total quantity of mtdna) by PCR in real time immediately after fusion, at 72 hours (embryos with 5 or more cells) and at 168 hours (blastocysts) after parthenogenic activation (Ferreira et al. submitted; Ferreira et al., 2007). The percentage of mtdna will be analyzed considering the following as effect - the cytoplasm used (B. indicus and H. sapiens), the moment of the analysis (0, 72 and 168 hours) and the interaction both factors.
Fundamental properties of Stem Cells
Stem cells Learning Goals: Define what a stem cell is and describe its general properties, using hematopoietic stem cells as an example. Describe to a non-scientist the current progress of human stem cell
More informationJohn Gurdon was testing the hypothesis of genomic equivalence or that when cells divide they retain a full genomic compliment.
1. (15 pts) John Gurdon won the 2012 Nobel Prize in Physiology or Medicine for work he did in the 1960 s. What was the major developmental hypothesis he set out to test? What techniques did he development
More informationhpsc Growth Medium DXF Dr. Lorna Whyte
hpsc Growth Medium DXF Dr. Lorna Whyte 27.06.2014 Training from Heidelberg Overview Background: Stem Cells Introduction: Human Pluripotent Stem Cells (hpsc) vs. Adult Stem Cells Promise of PSC Research
More informationStem Cel s Key Words:
Stem Cells Key Words: Embryonic stem cells, Adult stem cells, ips cells, self-renewal, differentiation, pluripotent, multipotent, Inner cell mass, Nuclear transfer (Therapeutic cloning), Feeder cells,
More informationMolecular Medicine. Stem cell therapy Gene therapy. Immunotherapy Other therapies Vaccines. Medical genomics
Molecular Medicine Molecular Medicine Stem cell therapy Gene therapy Tumor therapy Immunotherapy Other therapies Vaccines Genetic diagnostics Medical genomics Medication Diagnostics medicine: old desire
More informationANAT 2341 Embryology Lecture 18 Stem Cells
ANAT 2341 Embryology Lecture 18 Stem Cells 29 September 2010 Dr Antonio Lee Neuromuscular & Regenera
More informationStem Cells & Neurological Disorders. Said Ismail Faculty of Medicine University of Jordan
Stem Cells & Neurological Disorders Said Ismail Faculty of Medicine University of Jordan Outline: - Introduction - Types & Potency of Stem Cells - Embryonic Stem Cells - Adult Stem Cells - ipscs -Tissue
More informationANNOUNCEMENTS. HW2 is due Thursday 2/4 by 12:00 pm. Office hours: Monday 12:50 1:20 (ECCH 134)
ANNOUNCEMENTS HW2 is due Thursday 2/4 by 12:00 pm. Office hours: Monday 12:50 1:20 (ECCH 134) Lectures 6 8 Outline Stem Cell Division - symmetric - asymmetric Stem cell lineage potential - pluripotent
More informationLIFE. How-to 2 Cloning and Epigenetics. More great student questions of the day. 1. Reproductive vs therapeutic cloning
More great student questions of the day. Q: Are all cells that are pluripotent also stem cells? A: No! Many early embryonic cells are pluripotent, but do not self-renew, and eventually differentiate. Q:
More informationStem Cell Research 101
Stem Cell Research : A promising type of bioscience research The Stem Cell debate and the impact of the induced pluripotent stem cell procedure Why Is Vocabulary Important? Key terms frame the debate Mature
More informationCloning. 1. What is cloning: Natural and artificial 2. Cloning of what? 3. Embryonic development of multi-cellular organisms:
Cloning 1. What is cloning: Natural and artificial 2. Cloning of what? 3. Embryonic development of multi-cellular organisms: cell division, morphogenesis, differentiation 2. Plant cloning 3. Animal cloning
More informationStem cell: a cell capable of 1) tissue plasticity - make different cell types 2) infinite self renewal through asymmetric division
Stem cell: a cell capable of 1) tissue plasticity - make different cell types 2) infinite self renewal through asymmetric division stem cell stem cell skin muscle nerve Properties of STEM cells Plasticity
More informationXeno-Free Systems for hesc & hipsc. Facilitating the shift from Stem Cell Research to Clinical Applications
Xeno-Free Systems for hesc & hipsc Facilitating the shift from Stem Cell Research to Clinical Applications NutriStem Defined, xeno-free (XF), serum-free media (SFM) specially formulated for growth and
More informationDes cellules-souches dans le poumon : pourquoi faire?
Des cellules-souches dans le poumon : pourquoi faire? Karl-Heinz Krause Dept. of Pathology and Immunology, Medical Faculty Dept. of Genetic and Laboratory Medicine, University Hospitals Geneva, Switzerland
More informationNPTEL Biotechnology Tissue Engineering. Stem cells
Stem cells S. Swaminathan Director Centre for Nanotechnology & Advanced Biomaterials School of Chemical & Biotechnology SASTRA University Thanjavur 613 401 Tamil Nadu Joint Initiative of IITs and IISc
More informationDB3230 Midterm 1 11/15/2013 Name:
1. (15 pts) Nuclear cloning by John Gurdon was rarely successful in producing fertile adults. Why not? Explain why serial transplantation improves the success rate. What else could you do to improve the
More informationStem Cells: Introduction and Prospects in Regenerative Medicine.
Stem Cells: Introduction and Prospects in Regenerative Medicine www.gothamgazette.com/.../stemcell/stem_cell.jpg Ode to a Stem Cell, Part II by VCW There once was stem cell stuck in the hood Dividing endlessly,
More informationGenetic Basis of Development & Biotechnologies
Genetic Basis of Development & Biotechnologies 1. Steps of embryonic development: cell division, morphogenesis, differentiation Totipotency and pluripotency 2. Plant cloning 3. Animal cloning Reproductive
More informationStem Cell Services. Driving Innovation for Stem Cell Researchers
Driving Innovation for Stem Cell Researchers Stem Cell Services Partner with us and have access to the most advanced and comprehensive stem cell services available today. 675 W. Kendall St. Cambridge,
More informationLecture 24 Differentiation and stem cells
Lecture 24 Differentiation and stem cells *Stem cells and differentiation in plants Totipotency Stem cells in animals Therapeutic use Cloning Therapeutic Reproductive Therapeutic cloning in humans Stem
More informationDirected differentiation of human embryonic stem cells
Directed differentiation of human embryonic stem cells TECAN Symposium 2008 Biologics - From Benchtop to Production Wednesday 17 September 2008 Andrew Elefanty Embryonic Stem Cell Differentiation Laboratory,
More informationManufacturing and Characterization Challenges for Human Stem Cell Products
Manufacturing and Characterization Challenges for Human Stem Cell Products Center for Biomedicine and Genetics Beckman Research Institute of City of Hope Larry A. Couture, Ph.D January, 2009 Center for
More informationAssuring Pluripotency of ESC and ipsc Lines
Assuring Pluripotency of ESC and ipsc Lines Introduction Compared to other cell types, stem cells have the unique ability to self-renew their populations by dividing into identical daughter stem cells
More informationANAT 3231 Cell Biology Lecture 21 Stem Cells
ANAT 3231 Cell Biology Lecture 21 Stem Cells Outline What are Stem Cells? Totipotency - Pluripotency - Multipotency What are different sources of Stem Cells? Embryonic vs Adult Pros and Cons for each type
More informationWhat Are Stem Cells? [
Content 1. What Are Stem Cells? 2. Potency 3. Why Stem Cell Research? 4. Stem Cells Origins 5. Types of Stem Cells 6. Adult Stem Cells (ASCs) 7. Embryonic Stem Cells (ESCs) 8. Induced Pluripotent Stem
More informationEmbryonic development, epigenics and somatic cell nuclear transfer - The science and its social implications -
Embryonic development, epigenics and somatic cell nuclear transfer - The science and its social implications - Moshe Yaniv Unité d Expression Génétique et Maladies, Institut Pasteur, Paris, France September
More informationLesson 7A Specialized Cells, Stem Cells & Cellular Differentiation
Lesson 7A Specialized Cells, Stem Cells & Cellular Differentiation Learning Goals I can explain the concept of cell differentiation and cell specialization. I can explain how the cell structure relates
More informationA Survey of Genetic Methods
IBS 8102 Cell, Molecular, and Developmental Biology A Survey of Genetic Methods January 24, 2008 DNA RNA Hybridization ** * radioactive probe reverse transcriptase polymerase chain reaction RT PCR DNA
More informationTITLE: Induced Pluripotent Stem Cells as Potential Therapeutic Agents in NF1
AD Award Number: W81XWH-10-1-0181 TITLE: Induced Pluripotent Stem Cells as Potential Therapeutic Agents in NF1 PRINCIPAL INVESTIGATOR: Jonathan Chernoff, M.D., Ph.D. CONTRACTING ORGANIZATION: Institute
More informationBME 177. Engineering stem cells. Gayatri Pal Lecturer Biomolecular Engineering
BME 177 Engineering stem cells Gayatri Pal Lecturer Biomolecular Engineering Introduction Graduated from MCD Biology (Yeast Cell Cycle) -CIRM classes (Introduction to stem cell biology) Post-doc training
More informationUnit 1: DNA and the Genome. Sub-Topic (1.4) Cellular Differentiation
Unit 1: DNA and the Genome Sub-Topic (1.4) Cellular Differentiation Duncanrig 2016 Unit 1: DNA and the Genome Sub-Topic (1.4) Cellular Differentiation On completion of this subtopic I will be able to Cellular
More informationStem Cell Principle -
Effective Date: 31.10.2017 Doc ID: 20290214 Version: 1.0 Status: Approved Planned Effective Date: 31-Oct-2017 00:00 CET (Server Date) Stem Cell Principle - Rationale Research on human stem cells and their
More informationGenetic Technologies
Genetic Technologies Distinguish the terms biotechnology, recombinant DNA technology, transgenic organisms, genetic engineering Understand the two basic techniques to obtain selective fragments of DNA
More informationProf. Fahd M. Nasr. Faculty of Sciences Lebanese University Beirut, Lebanon.
Prof. Fahd M. Nasr Faculty of Sciences Lebanese University Beirut, Lebanon https://yeastwonderfulworld.wordpress.com/ Biol328 - B3212 Molecular Biotechnology Partial Exam Question I Explain the procedure
More informationLecture 17. Transgenics. Definition Overview Goals Production p , ,
Lecture 17 Reading Lecture 17: p. 251-256, 260-261 & 264-266 Lecture 18: p. 258-264, 508-524 Transgenics Definition Overview Goals Production p.251-256, 260-261, 264-266 315 Definition A transgenic animal
More informationJedi cells patrol the mouse
Jedi cells patrol the mouse Technical Journal Club Josephin Wagner 19.01.2016 12 VOL.13 NO.1 JANUARY 2016 NATURE METHODS Introduction JEDI= Just EGFP Death Inducing t- cells Specific CD-8 T cells All EGFP
More informationNature Biotechnology: doi: /nbt Supplementary Figure 1
Supplementary Figure 1 Schematic and results of screening the combinatorial antibody library for Sox2 replacement activity. A single batch of MEFs were plated and transduced with doxycycline inducible
More informationWill Stem Cells Finally Deliver Without Controversy?
Will Stem Cells Finally Deliver Without Controversy? Keith Gary, Ph.D. Director of Program Development Kansas City Area Life Sciences Institute Olathe North Life Sciences 1 February 2012 What s the Buzz?
More informationWhich of the following comes closest to your view? no genetic engineering whatsoever should be performed on humans.
Which of the following comes closest to your view? GREEN: BLUE: RED: YELLOW: no genetic engineering whatsoever should be performed on humans. gene therapy is OK, but nothing else. I m OK with gene therapy
More informationBiology 4361 Developmental Biology Lecture 4. The Genetic Core of Development
Biology 4361 Developmental Biology Lecture 4. The Genetic Core of Development The only way to get from genotype to phenotype is through developmental processes. - Remember the analogy that the zygote contains
More informationGenetics and Genomics in Medicine Chapter 9 Questions
Genetics and Genomics in Medicine Chapter 9 Questions Multiple Choice Questions Question 9.1 Which, if any, of the following can be classified as a type of augmentation therapy? a) Treatment using a small
More informationPhysicsAndMathsTutor.com. Question Number. Answer Additional guidance Mark. 1(a) 1. reference to stem cells being {totipotent / pluripotent} ;
1(a) 1. reference to stem cells being {totipotent / pluripotent} ; 2. can specialise or differentiate / can give rise to {differentiated / specialised} cells ; 3. idea that these can replace damaged cells
More informationCat# Product Name amounts h NANOG (RFP-Bsd) inducible particles
Premade Lentiviral Particles for ips Stem Factors For generating induced pluripotent stem (ips) cells or other applications. LVP003 LVP004 LVP005 LVP006 LVP007 LVP008 RESEARCH USE ONLY, not intend for
More informationStem and cell gene therapy. Lecture 13
Stem and cell gene therapy Lecture 13 24th January 2011 1. Stem cells types and potential 2. (Very) recent achievements in stem cell research 3. Research on stem cells at Department of Medical Biotechnology
More informationCloning genes into animals. Transgenic animal carries foreign gene inserted into its genome.
Cloning genes into animals Transgenic animal carries foreign gene inserted into its genome. Transgenic goats Ch. 10 pg. 281 Produce human protein (drug) in milk Pharming Transgenic animals to produce human
More informationImmunogenicity of Stem Cells in Therapeutic Applications. MDPB-Registry meeting nov 25th Stem cell immunogenicity in therapeutic applications
Immunogenicity of Stem Cells in Therapeutic Applications MDPB-Registry meeting nov 25th 2016 Stem cell immunogenicity in therapeutic applications Has it been underestimated? Transplantation of any type
More informationConcepts and Methods in Developmental Biology
Biology 4361 Developmental Biology Concepts and Methods in Developmental Biology June 16, 2009 Conceptual and Methodological Tools Concepts Genomic equivalence Differential gene expression Differentiation/de-differentiation
More informationProtocol Using the Reprogramming Ecotropic Retrovirus Set: Mouse OSKM to Reprogram MEFs into ips Cells
STEMGENT Page 1 OVERVIEW The following protocol describes the reprogramming of one well of mouse embryonic fibroblast (MEF) cells into induced pluripotent stem (ips) cells in a 6-well format. Transduction
More informationDec 04, 2013
Stem Cells Junfeng Ji ( 纪俊峰 ), PhD Professor Research Center of Stem Cell and Developmental Biology School of Medicine Zhejiang University Email: jijunfeng@zju.edu.cn Dec 04, 2013 Totipotent Pluripotent
More informationDirect Reprogramming of Fibroblasts into Cardiomyocytes
Direct Reprogramming of Fibroblasts into Cardiomyocytes G. Hasenfuss No conflict Heart Center Heart Research Center Göttingen Georg-August-University Göttingen Cardiac Regeneration Options in 5/2011 Stem
More informationBiotechnology. Chapter 20. Biology Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for
Chapter 20 Biotechnology PowerPoint Lecture Presentations for Biology Eighth Edition Neil Campbell and Jane Reece Lectures by Chris Romero, updated by Erin Barley with contributions from Joan Sharp Copyright
More informationChapter 8 Healthcare Biotechnology
Chapter 8 Healthcare Biotechnology Outline: 8.1 Introduction 8.2 Biopharming 8.3 Models of Human Disease 8.4 Detecting and Diagnosing Human Disease 8.5 Monoclonal Antibodies 8.6 Gene Therapy 8.7 Tissue
More informationPremade Lentiviral Particles for human ips Stem Factors
Premade Lentiviral Particles for human ips Stem Factors For generating induced pluripotent stem (ips) cells or other applications RESEARCH USE ONLY, not for diagnostics or therapeutics Cat# Product Name
More informationKEY Reproductive cloning Therapeutic cloning
1. (20 pts) Define Reproductive and Therapeutic cloning. Make sure your descriptions clearly distinguish the critical differences between them. Describe an example of each. Reproductive cloning refers
More informationDifferentiation. Ahmed Ihab Abdelaziz MD, PhD Associate Prof. Of Molecular Medicine NewGiza University (NGU)
Differentiation Ahmed Ihab Abdelaziz MD, PhD Associate Prof. Of Molecular Medicine NewGiza University (NGU) 1 Developmental Genetics Objectives: Explain how a differentiated cell achieves and maintains
More informationWhat are the origins of medical practice? Humans have been involved with medical biotechnology
Name: Score: / Quiz 8 on Medical Biotechnology Part 1 What are the origins of medical practice? Humans have been involved with medical biotechnology A. since the cloning of the insulin gene in the 1980s
More informationSupplementary Data. Supplementary Methods Three-step protocol for spontaneous differentiation of mouse induced pluripotent stem (embryonic stem) cells
Supplementary Data Supplementary Methods Three-step protocol for spontaneous differentiation of mouse induced pluripotent stem (embryonic stem) cells Mouse induced pluripotent stem cells (ipscs) were cultured
More informationEdexcel (B) Biology A-level
Edexcel (B) Biology A-level Topic 7: Modern Genetics Notes Using Gene Sequencing Genome = all of an organism s DNA, including mitochondrial/chloroplast DNA. Polymerase chain reaction (PCR) is used to amplify
More informationFuture of Stem Cell Engineering. Jaeseung Jeong, Ph.D Department of Bio and Brain Engineering KAIST
Future of Stem Cell Engineering i Jaeseung Jeong, Ph.D Department of Bio and Brain Engineering KAIST Keywords of Stem Cell Engineering g Embryo and Fetus (Foetus) Adult stem cells and embryonic stem cells
More informationRegenerative Medicine and Stem Cell Therapies
Regenerative Medicine and Stem Cell Therapies Regenerative Medicine Major component of successful regenerated / tissue engineered organs Scaffolds A critical element is the binding of the repopulating
More informationThe NYSCF Research Institute
Regenerative Medicine Research Update Susan L. Solomon The NYSCF Research Institute New York Pharma Forum February 25, 2016 Regenerative Medicine Research Regenerative medicine uses laboratory grown human
More informationDevelopmental Biology 3230 Exam 1 (Feb. 6) NAME
DevelopmentalBiology3230Exam1(Feb.6)NAME 1. (10pts) What is a Fate Map? How would you experimentally acquire the data to draw a Fate Map? Explain what a Fate Map does and does not tell you about the mechanisms
More informationGuided teaching hours: 4 hours
Cell division Chapter overview Guided teaching hours: 4 hours In this chapter, students will learn about the process of cell division and after finishing the chapter should be able to describe the three
More informationPremade Lentiviral Particles for ips Stem Factors: Single vector system. For generation of induced pluripotent stem (ips) cells and other applications
Premade Lentiviral Particles for ips Stem Factors: Single vector system For generation of induced pluripotent stem (ips) cells and other applications RESEARCH USE ONLY, not for diagnostics or therapeutics
More informationSUPPLEMENTARY INFORMATION
DOI: 10.1038/ncb2239 Hepatocytes (Endoderm) Foreskin fibroblasts (Mesoderm) Melanocytes (Ectoderm) +Dox rtta TetO CMV O,S,M,K & N H1 hes H7 hes H9 hes H1 hes-derived EBs H7 hes-derived EBs H9 hes-derived
More informationTherapeutic Cell Replacement. Steven McLoon Department of Neuroscience University of Minnesota
Therapeutic Cell Replacement Steven McLoon Department of Neuroscience University of Minnesota 1 Neuronal Death Neurons are lost due to four main causes: Trauma Toxin Hypoxia (typically loss of air or blood
More informationProtocol Reprogramming MEFs using the Dox Inducible Reprogramming Lentivirus Set: Mouse OKSM
STEMGENT Page 1 OVERVIEW The following protocol describes the reprogramming of one well of mouse embryonic fibroblasts (MEFs) into induced pluripotent stem (ips) cells in a 6-well format. Transduction
More informationContribution and Mobilization of Mesenchymal Stem Cells in a mouse model of carbon tetrachloride-induced liver fibrosis
Contribution and Mobilization of Mesenchymal Stem Cells in a mouse model of carbon tetrachloride-induced liver fibrosis Yan Liu 1,*, Zhipeng Han 1,*, Yingying Jing 1,*, Xue Yang 1, Shanshan Zhang 1, Chen
More informationUnderstanding Stem Cells The Conference 1 Basics. 1 Basics
Understanding Stem Cells The Conference 1 Basics 1 Basics Teacher Comments i In this module, the students work on the basics of stem cell research. As participants in a scientific conference, they prepare
More informationGenetics Lecture 19 Stem Cells. Stem Cells 4/10/2012
Genetics Lecture 19 Stem Cells Stem Cells Much of the excitement about stem cells in the scientific and medical communities comes from their largely untapped and unproven potential for treating human conditions)
More informationDisease Clinical features Genotype
Disease Clinical features Genotype Alpha 1 Antitrypsin deficiency (A1ATD) Patient 1 65 year old caucasian male, liver transplant recipient, explant biopsy confirmed A1ATD induced liver cirrhosis Patient
More informationSTEM CELL RESEARCH PRIMER
STEM CELL RESEARCH PRIMER WHAT YOU NEED TO KNOW ABOUT STEM CELLS AND STEM CELL RESEARCH What Stem Cells Are And Why They Are Important Stem cells are the body s very own internal repair system. They are
More informationCULTURE ENGINEERING DIFFERENTIATION CHARACTERIZATION. Stem Cell Research Solutions Promotional offers
CULTURE ENGINEERING DIFFERENTIATION CHARACTERIZATION Stem Cell Research Solutions Promotional offers Stem Cell research products For more than a decade, we have provided you with key tools to address challenges
More informationWHAT IS EMBRYONIC STEM CELLS
31 March, 2018 WHAT IS EMBRYONIC STEM CELLS Document Filetype: PDF 436.17 KB 0 WHAT IS EMBRYONIC STEM CELLS Explore Current Stem Cell Treatments. Embryonic stem cells - Embryonic stem cells include those
More informationStem Cells, Regenerative Medicine and cgmp (GTP)
Stem Cells, Regenerative Medicine and cgmp (GTP) Encompass Stem cell based therapies activities Collection source Purification Isolation from other cell types if needed Manipulation Minimal vs Moderate
More informationPluripotent Stem Cells From Research to Therapy
Pharma&Biotech BioResearch Pluripotent Stem Cells From Research to Therapy Webinar 16 June 2015 / Speaker: Mr. Andrew Winner 17 June 2015 / Speaker: Dr. Heiko Bueth Lonza Walkersville, Inc., Walkersville,
More informationA"Review" " " " " " " " " " " " " " Going"Uphill:"Inducing"Pluripotency." By#Ben#Laffin#
A"Review" " " " " " " " " " " " " " Going"Uphill:"Inducing"Pluripotency." By#Ben#Laffin# FromtheidealizedepigeneticlandscapeofC.H.Waddingtontothemodernuseofepigeneticregulatory factors,theabilitytorevertacelltoapluripotentstatehasbeenadreamofbiologistsfornearlyseventy
More informationips cell reprogramming
ips cell reprogramming Student: Sophie de Boer Supervisor: Koen Braat June 2009 August 2009 Table of Contents Table of Contents 2 Introduction -Mammalian Development 3 -Pluripotency 3 -Embryonic stem cells
More informationChapter 11. How Genes Are Controlled. Lectures by Edward J. Zalisko
Chapter 11 How Genes Are Controlled PowerPoint Lectures for Campbell Essential Biology, Fifth Edition, and Campbell Essential Biology with Physiology, Fourth Edition Eric J. Simon, Jean L. Dickey, and
More informationStem Cells: Ethics and Oversight May 24, Sidney H. Golub, Ph.D. Interim Director Sue & Bill Gross Stem Cell Research Center
Stem Cells: Ethics and Oversight May 24, 2017 Sidney H. Golub, Ph.D. Interim Director Sue & Bill Gross Stem Cell Research Center Nobel Laureates 2012 John Gurdon Shinya Yamanaka Pluripotent Stem Cell PLURIPOTENT
More informationBiotechnology. Professor Andrea Garrison Biology 11 Illustrations 2010 Pearson Education, Inc., unless otherwise noted
Biotechnology Professor Andrea Garrison Biology 11 Illustrations 2010 Pearson Education, Inc., unless otherwise noted Biotechnology Any technical procedure used to isolate, analyze or manipulate genes
More informationProfessor Martin Pera. University of Melbourne Melbourne
Professor Martin Pera University of Melbourne Melbourne Human Pluripotent Stem Cells: The Future is Now Martin Pera University of Southern California University of Melbourne Walter and Eliza Hall Institute
More informationCIRM - MRC Human Somatic Cell Nuclear Transfer Workshop Report June 13-14, 2010
CIRM - MRC Human Somatic Cell Nuclear Transfer Workshop Report June 13-14, 2010 CHAPTER 1. EXECUTIVE SUMMARY Somatic cell nuclear transfer (SCNT), or nuclear reprogramming achieved through transplantation
More informationIN THE UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD. BioGatekeeper, Inc. Petitioner
IN THE UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD BioGatekeeper, Inc. Petitioner v. Kyoto University Patent Owner U.S. Patent No. 8,058,065 to Yamanaka et al. Issue
More informationA Novel Platform to Enable the High-Throughput Derivation and Characterization of Feeder-Free Human ipscs
Supplementary Information A Novel Platform to Enable the High-Throughput Derivation and Characterization of Feeder-Free Human ipscs Bahram Valamehr, Ramzey Abujarour, Megan Robinson, Thuy Le, David Robbins,
More informationThe New News in Stem Cell Research Andrés Bratt-Leal, PhD 12/1/2017
The New News in Stem Cell Research Andrés Bratt-Leal, PhD 12/1/2017 Cell Therapy and Parkinson s Disease Very specific neural degeneration >50% of DA neurons are gone by diagnosis 1 million in the USA,
More informationNational Institute of Science and Technology in. Edital Nº 15/2008 MCT/CNPq/FNDCT/CAPES/FAPEMIG/FAPERJ/FAPESP
National Institute of Science and Technology Edital Nº 15/2008 MCT/CNPq/FNDCT/CAPES/FAPEMIG/FAPERJ/FAPESP National Institute of Science and Technology in Stem Cell and Cell Therapy INCTC Coordinator: Roberto
More informationCloning and Epigenetics. Developmental Readout. Foundations. Human issues. Stem cells. Cloning. Axon guidance.
7.72 12.4.06 Cloning and Epigenetics Human issues Cloning Stem cells Developmental Readout Axes Organ formation Axon guidance 3D structure Analysis Model + + organisms Foundations Principles 1 1 Cloning:
More informationDeveloping Targeted Stem Cell Therapeutics for Cancer. Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013
Developing Targeted Stem Cell Therapeutics for Cancer Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013 The Challenge of Drug Delivery for Brain Cancer Stem Cells
More informationCurrent progress and prospects of induced pluripotent stem cells
Science in China Series C: Life Sciences 2009 SCIENCE IN CHINA PRESS Springer Special Topic Review www.scichina.com life.scichina.com www.springerlink.com Current progress and prospects of induced pluripotent
More informationVersatility and performance of Lipofectamine Stem Transfection Reagent
PPLICTION NOTE Stem Transfection Reagent Versatility and performance of Stem Transfection Reagent Introduction The ability of stem cells to self-renew and differentiate into various specialized cell types
More informationHuman therapeutic cloning
COMMENTARY Somatic cell nuclear reprogramming in livestock species is now routine in many laboratories. Here, Robert Lanza, Jose Cibelli and Michael West discuss how these techniques may soon be used to
More informationSupplementary Figure 1.
Supplementary Figure 1. Quantification of western blot analysis of fibroblasts (related to Figure 1) (A-F) Quantification of western blot analysis for control and IR-Mut fibroblasts. Data are expressed
More informationMid-term review. Recitation5 03/31/2014. Stem Cell Biology and Function W4193 1
Mid-term review Recitation5 03/31/2014 Stem Cell Biology and Function W4193 1 What to expect in the midterm2 It will be all so far but mainly whatever was NOT covered by the previous mid-term- not a huge
More informationInduced Stem Cells in Research and Therapy of Neuropsychiatric Disorders
Berlin-Brandenburg Center for Regenerative Therapies Induced Stem Cells in Research and Therapy of Neuropsychiatric Disorders Josef Priller Department of Neuropsychiatry Laboratory of Molecular Psychiatry
More informationProtocol Reprogramming Human Fibroblasts into ips Cells using the Stemgent Reprogramming Lentivirus Set: Human OKSM
STEMGENT Page 1 Reprogramming Lentivirus Set: Human OKSM OVERVIEW The following procedure describes the reprogramming of BJ Human Fibroblasts (BJ cells) to induced pluripotent stem (ips) cells using the
More informationStem Cells. Part 1: What is a Stem Cell? STO Stem cells are unspecialized. What does this mean?
STO-120 Stem Cells Part 1: What is a Stem Cell? Stem cells differ from other kinds of cells in the body. When a stem cell divides by mitosis, each new cell has the potential to either remain a stem cell
More informationProtocol Using a Dox-Inducible Polycistronic m4f2a Lentivirus to Reprogram MEFs into ips Cells
STEMGENT Page 1 OVERVIEW The following protocol describes the transduction and reprogramming of one well of Oct4-GFP mouse embryonic fibroblasts (MEF) using the Dox Inducible Reprogramming Polycistronic
More informationGenomic analysis of induced pluripotent stem (ips) cells: routes to reprogramming
DOI 10.1002/bies.200800204 Genomic analysis of induced pluripotent stem (ips) cells: routes to reprogramming Ashlin Kanawaty and Jeffrey Henderson * Leslie Dan Faculty of Pharmacy, University of Toronto,
More informationAndrew Burnett, PhD DeGroot Center, Sanford Health Ethics & Humanities Section, SSOM USD
Stem Cells in Context Andrew Burnett, PhD DeGroot Center, Sanford Health Ethics & Humanities Section, SSOM USD Overview Basic science of stem cells Some possible biomedical applications The federal funding
More information